This factor can bind to insulin and IGF-I receptors, mimicking endogenous insulin effects, increasing glucose uptake by tissues, and inhibiting growth hormone secretion and its hypoglycemia regulatory response, resulting in hypoglycemia and, in severe cases, epilepsy (89). This evidence concerns the gene IGF1R and epilepsy.